Jiangsu Apon (China) Investor Sentiment

300753 Stock   16.88  1.08  6.01%   
About 61% of Jiangsu Apon's investor base is looking to short. The analysis of overall sentiment of trading Jiangsu Apon Medical stock suggests that many investors are alarmed at this time. The current market sentiment, together with Jiangsu Apon's historical and current headlines, can help investors time the market. In addition, many technical investors use Jiangsu Apon Medical stock news signals to limit their universe of possible portfolio assets.
  
over three weeks ago at news.google.com         
Optimistic Investors Push Jiangsu Apon Medical Technology Co., Ltd. Shares Up 26 percent But Growth ...
Google News at Macroaxis
over three months ago at news.google.com         
The five-year loss for Jiangsu Apon Medical Technology shareholders likely driven by its shrinking e...
Google News at Macroaxis
over six months ago at news.google.com         
Optimism around Jiangsu Apon Medical Technology delivering new earnings growth may be shrinking ... ...
Google News at Macroaxis
over six months ago at news.google.com         
Stanley Druckenmiller makes surprising small-cap and AI stock bet - TheStreet
Google News at Macroaxis
over six months ago at news.google.com         
Jiangsu Apon Medical Technology Full Year 2023 Earnings EPS CN0.066 - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Insiders are the top stockholders in Jiangsu Apon Medical Technology Co., Ltd. , and the recent 12 p...
Google News at Macroaxis
over six months ago at news.google.com         
Jiangsu Apon Medical Technology Co., Ltd.s Share Price Boosted 41 percent But Its Business Prospects...
Google News at Macroaxis
over six months ago at news.google.com         
Jiangsu Apon Medical Technology adds CN265m to market cap in the past 7 days, though investors from ...
Google News at Macroaxis
over a year ago at news.google.com         
Fenofibrate ameliorates RPE injury DDDT - Dove Medical Press
Google News at Macroaxis
over a year ago at news.google.com         
RKLY INVESTOR ALERT Robbins Geller Rudman Dowd LLP Files Class Action Lawsuit Against SC Health Hold...
Google News at Macroaxis
over a year ago at news.google.com         
Cooley Supports Jiangsu Hengrui in Two Global License Agreements - Cooley LLC
Google News at Macroaxis
over a year ago at news.google.com         
HDL-CLDL-C and Cerebral White Matter Hyperintensities IJGM - Dove Medical Press
Google News at Macroaxis
over a year ago at news.google.com         
Energy Vault Announces Five Additional EVx Gravity Energy ... - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaqs Minimum Bid Price Rule - Yahoo Fina...
Google News at Macroaxis
over a year ago at news.google.com         
GSK signs 1B licensing deal with Chinas Hansoh for ADC ... - BioWorld Online
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Jiangsu Apon that are available to investors today. That information is available publicly through Jiangsu media outlets and privately through word of mouth or via Jiangsu internal channels. However, regardless of the origin, that massive amount of Jiangsu data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Jiangsu Apon news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Jiangsu Apon relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Jiangsu Apon's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Jiangsu Apon alpha.

Jiangsu Apon Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Optimistic Investors Push Jiangsu Apon Medical Technology Co., Ltd. Shares Up 26 percent But Growth Is Lacking - Simply Wall St
12/05/2024

Complementary Tools for Jiangsu Stock analysis

When running Jiangsu Apon's price analysis, check to measure Jiangsu Apon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jiangsu Apon is operating at the current time. Most of Jiangsu Apon's value examination focuses on studying past and present price action to predict the probability of Jiangsu Apon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jiangsu Apon's price. Additionally, you may evaluate how the addition of Jiangsu Apon to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges